{"database": "lobbying", "table": "lobbying_activities", "rows": [[1665790, "b43cb08a-989c-4250-a58f-96b479ddceaa", "Q1", "RAMPY NORTHRUP LLC", 401103289, "AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)", 2015, "first_quarter", "MED", "Implementation of P.L.113-93, Protecting Access to Medicare Act of 2014 (changes to reimbursement for clinical laboratory services). Proposals concerning the Stark Law's in-office ancillary services exception. Policies impacting Medicare reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. H.R.2, Medicare Access and CHIP Reauthorization Act of 2015.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2015-04-17T09:34:34.770000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1665790"], "units": {}, "query_ms": 1.0740500001702458, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}